STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorOregon Health and Science University

About this trial

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.

Eligibility criteria

Qualifiers

Adult caring for family member with FTD.

Provides 4 or more hours of care/week. Does not have to reside with.

Identifies at least 2 moderately upsetting behaviors in the person with FTD.

Speaks and understands English to be able to participate in intervention.

Disqualifiers

No Frontotemporal Degeneration diagnosis.

Unable to leave Care Partner during STELLA-FTD sessions.

Enrolled in hospice.

Unable to find activity for Care Recipient during STELLA-FTD sessions to allow Care Partner to work privately with Guide and other Care Partners.

Trial design

Treatments tested in this trial

  • STELLA-FTD Control
  • STELLA-FTD Test

Treatment groups

640 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Oregon Health and Science University

Lead sponsor

National Institute on Aging (NIA)

Collaborator